Why the study?
NAFLD and T2DM are independent risk factors for CVD, but the clinical utility of liver fat quantification for determining CVD risk in T2DM patients required examination.
Does higher liver fat quantification increase calculated CVD risk in adults aged ≥50 with type 2 diabetes?
Does higher liver fat quantification increase calculated CVD risk in adults aged ≥50 with type 2 diabetes?
Higher liver fat content quantified by MRI-PDFF is independently associated with increased calculated CVD risk in older adults with type 2 diabetes.
Answers are grounded in this paper and cite their sources.
May support liver fat as CVD risk marker in T2DM; leaves open need for prospective validation before clinical use.
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are independent risk factors for cardiovascular disease (CVD). AIMS: To examine the clinical utility of liver fat quantification for determining CVD risk among a well-phenotyped cohort of patients with T2DM. METHODS: This was a cross-sectional analysis of a prospective cohort of adults aged ≥50 with T2DM. Liver fat was quantified with magnetic resonance imaging proton-density-fat-fraction (MRI-PDFF), an advanced imaging-based biomarker. Patients were stratified into a higher liver fat group (MRI-PDFF ≥ 14.6%), and a lower liver fat group (MRI-PDFF < 14.6%). The co-primary outcomes were CVD risk determined by Framingham and Atherosclerotic Cardiovascular Disease (ASCVD) risk scores. High CVD risk was defined by risk scores ≥20%. In multivariable analysis, adjusted for age, gender, race, and BMI, patients in the higher liver fat group had higher CVD risk [OR = 4.04 (95% CI: 2.07-7.88, p < 0.0001)] and ASCVD risk score [OR = 2.85 (95% CI: 1.19-6.83, p = 0.018)], respectively. CONCLUSION: Higher liver fat content increases CVD risk independently of age, gender, ethnicity and BMI. These findings raise the question whether liver fat quantification should be incorporated into risk calculators to further stratify those with higher CVD risk.
No takes yet. Share an insight, caveat, or question.
Kuo et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: